Guardant Health Eyes Earlier Breakeven As Liquid Biopsy Boosts Outlook

Lab Test Innovator Focuses On US Coverage Gaps

Guardant Health expects to break even by 2028. A positive pricing outlook for the Guardant 360 lab test could bring this forward by maybe one year, CFO Mike Bell told the Jefferies London Healthcare Conference.

Guardant Health Panel Jefferies London Healthcare Conference 2024
Guardant Health Panel Jefferies London Healthcare Conference 2024

More from Conferences

More from Business